| Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States H Kalish, C Klumpp-Thomas, S Hunsberger, HA Baus, MP Fay, ... Science Translational Medicine 13 (601), eabh3826, 2021 | 139 | 2021 |
| Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress A Thomas, N Takahashi, VN Rajapakse, X Zhang, Y Sun, M Ceribelli, ... Cancer Cell 39 (4), 566-579. e7, 2021 | 126 | 2021 |
| Identification of compounds for butyrylcholinesterase inhibition S Li, AJ Li, J Travers, T Xu, S Sakamuru, C Klumpp-Thomas, R Huang, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (10), 1355-1364, 2021 | 28 | 2021 |
| Profiling the Tox21 chemical collection for acetylcholinesterase inhibition S Li, J Zhao, R Huang, J Travers, C Klumpp-Thomas, W Yu, ... Environmental Health Perspectives 129 (4), 047008, 2021 | 22 | 2021 |
| Quantitative chemotherapeutic profiling of gynecologic cancer cell lines using approved drugs and bioactive compounds K Gorshkov, N Sima, W Sun, B Lu, W Huang, J Travers, ... Translational Oncology 12 (3), 441-452, 2019 | 17 | 2019 |
| Cytotoxic profiling of annotated and diverse chemical libraries using quantitative high-throughput screening OW Lee, S Austin, M Gamma, DM Cheff, TD Lee, KM Wilson, J Johnson, ... SLAS DISCOVERY: Advancing Life Sciences R&D 25 (1), 9-20, 2020 | 12 | 2020 |
| Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma Y Yang, A Bolomsky, T Oellerich, P Chen, M Ceribelli, B Häupl, ... Nature communications 13 (1), 5469, 2022 | 10 | 2022 |
| Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation M Ooka, J Zhao, P Shah, J Travers, C Klumpp-Thomas, X Xu, R Huang, ... Archives of Toxicology 96 (7), 1975-1987, 2022 | 10 | 2022 |
| Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4 DM Cheff, Q Cheng, H Guo, J Travers, C Klumpp-Thomas, M Shen, ... Redox Biology 63, 102719, 2023 | 6 | 2023 |
| Cross-platform Bayesian optimization system for autonomous biological assay development S Elder, C Klumpp-Thomas, A Yasgar, J Travers, S Frebert, KM Wilson, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 26 (6), 579-590, 2021 | 5 | 2021 |
| Mapping a pandemic: SARS-CoV-2 seropositivity in the United States. medRxiv 2021 H Kalish, C Klumpp-Thomas, S Hunsberger, HA Baus, MP Fay, ... Google Scholar, 0 | 4 | |
| SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States TB Ngo, M Karkanitsa, KM Adusei, LA Graham, EE Ricotta, JR Darrah, ... medRxiv, 2021 | 1 | 2021 |
| Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts Y Arakawa, U Jo, S Kumar, NY Sun, F Elloumi, A Thomas, N Roper, ... Cancer Research Communications 4 (3), 834-848, 2024 | | 2024 |
| Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma Y Yang, A Bolomsky, T Oellerich, P Chen, M Ceribelli, B Häupl, ... nature communications 13, 2022 | | 2022 |
| Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States (preprint) H Kalish, C Klumpp-Thomas, S Hunsberger, HA Baus, MP Fay, ... | | 2021 |
